Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.

× No keyword cloud information.

21 in total

1. Noninvasive assessment of clinical response to oral propranolol therapy.

Authors: W Frishman; C Smithen; B Befler; P Kligfield; T Killip
Journal: Am J Cardiol Date: 1975-05 Impact factor: 2.778

2. Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease.

Authors: L A Nordstrom; F MacDonald; F L Gobel
Journal: Chest Date: 1975-03 Impact factor: 9.410

3. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

Authors: L E Teichholz; T Kreulen; M V Herman; R Gorlin
Journal: Am J Cardiol Date: 1976-01 Impact factor: 2.778

4. Echocardiographic evaluation of left ventricular size and function and function and its application in coronary artery disese.

Authors: M L Johnson
Journal: Adv Cardiol Date: 1976

5. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.

Authors: R J Lee; D B Evans; S H Baky; R J Laffan
Journal: Eur J Pharmacol Date: 1975 Sep-Oct Impact factor: 4.432

6. Unwanted effects of propranolol.

Authors: S A Stephen
Journal: Am J Cardiol Date: 1966-09 Impact factor: 2.778

7. Experience with a multicenter study in the evaluation of propranolol as an effective antianginal agent.

Authors: W S Frankl; W K Smith; F D Rose; R MacMillan; R Gomez; M Harkins
Journal: J Clin Pharmacol Date: 1974-01 Impact factor: 3.126

8. Reproducibility of a multi-stage near maximal treadmill test for exercise tolerance in angina pectoris.

Authors: P E Smokler; R N MacAlpin; A Alvaro; A A Kattus
Journal: Circulation Date: 1973-08 Impact factor: 29.690

9. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS.

Authors: W L Henry; C E Clark; S E Epstein
Journal: Circulation Date: 1973-02 Impact factor: 29.690

10. The flow volume loop: normal standards and abnormalities in chronic obstructive pulmonary disease.

Authors: H Bass
Journal: Chest Date: 1973-02 Impact factor: 9.410

3 in total

1. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.

Authors: M Condorelli; G Brevetti; M Chiariello; D Miceli; G Lavecchia; G Paudice; S Verrienti
Journal: Br J Clin Pharmacol Date: 1982-06 Impact factor: 4.335

Review 2. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors: R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal: Drugs Date: 1980-07 Impact factor: 9.546

3. Right ventricular performance in essential hypertension after beta-blockade.

Authors: J Ferlinz; J L Easthope; D Hughes; J Siegel; J Tobis; W S Aronow
Journal: Br Heart J Date: 1981-07

3 in total